Search

Search Constraints

You searched for: Author/Creator Portelance, Lorraine

Search Results

1. 76: IMRT for Vulvar Carcinoma: Changes in Practice Over 5 Years. (September 2016)

2. ACTR-32. NRG ONCOLOGY RTOG 1205: RANDOMIZED PHASE II TRIAL OF CONCURRENT BEVACIZUMAB AND RE-IRRADIATION VS. BEVACIZUMAB ALONE AS TREATMENT FOR RECURRENT GLIOBLASTOMA. (11th November 2019)

6. Executive summary of the American Radium Society appropriate use criteria for management of uterine clear cell and serous carcinomas. Issue 12 (24th November 2022)

7. Factors contributing to delays in initiation of front-line cervical cancer therapy: disparities in a diverse south Florida population. Issue 11 (5th October 2022)

8. Impact of quantization algorithm and number of gray level intensities on variability and repeatability of low field strength magnetic resonance image-based radiomics texture features. (December 2020)

9. NRG Oncology/RTOG 0921: A phase 2 study of postoperative intensity‐modulated radiotherapy with concurrent cisplatin and bevacizumab followed by carboplatin and paclitaxel for patients with endometrial cancer. Issue 13 (6th April 2015)

10. NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma. Issue 6 (20th February 2023)